Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dThaCfbwoceMxbzFEjVE

  ADVERTISEMENT  
October 1, 2012
Sign upForwardArchiveAdvertise
News for nurse practitioners

  Health Care News 
  • Rheumatology group issues new gout guidelines
    The American College of Rheumatology released new guidelines on how to manage and treat gout. The group recommended xanthine oxidase inhibitors, either allopurinol or febuxostat, as first-line therapy to reduce uric acid levels. A uricosuric agent such as probenecid, fenofibrate or losartan can be added if the target serum urate level cannot be achieved with xanthine oxidase inhibitors alone. The guidelines were published in the journal Arthritis Care & Research. MedPage Today (free registration) (9/29), DailyRx.com (9/30) LinkedInFacebookTwitterEmail this Story
  • Sleep deprivation raises type 2 diabetes risk in teens
    Lack of sleep was linked to higher levels of insulin resistance in teens, increasing their risk of developing type 2 diabetes, a study in the journal SLEEP indicated. The researchers found that one extra hour of sleep was associated with a 9% improvement in insulin resistance in teens who usually slept for only six hours a night. eMaxHealth.com (9/30) LinkedInFacebookTwitterEmail this Story
  • Better follow-up testing after hep B vaccination needed in babies
    Data from the Enhanced Perinatal Hepatitis B Case Management Projects showed that only 64% of babies born to mothers infected with hepatitis B received recommended post-vaccination blood testing. Of those, 93% were protected from infection while 1% got infected and 3% were susceptible to infection, CDC researchers wrote in the Morbidity and Mortality Weekly Report. HealthDay News (9/27) LinkedInFacebookTwitterEmail this Story
  • CIMT measurements higher in children with kidney disease
    Children diagnosed with chronic kidney disease were more likely to have increased carotid intima-media thickness than those without the condition, Johns Hopkins University researchers found. They also noted that greater cIMT was linked to both hypertension and dyslipidemia. The findings appear in the Clinical Journal of the American Society of Nephrology. DoctorsLounge.com/HealthDay News (9/27) LinkedInFacebookTwitterEmail this Story
  Pharmaceutical News 
  • FDA widens approval of calcipotriene to include scalp psoriasis
    The FDA approved Stiefel's Sorilux, or calcipotriene, to treat adults with psoriasis of the scalp. The therapy is already approved for psoriasis of other body parts. "We believe this additional indication for Sorilux foam will help meet the needs of both patients and physicians," said Susan Learned, Stiefel's medicine-development head for dermatology research and development. Drug Store News (9/28) LinkedInFacebookTwitterEmail this Story
  • Diabetes patients on DPP-IV inhibitors have lower heart risks
    Data on 8,544 type 2 diabetes patients revealed those who took dipeptidyl peptidase-4 inhibitors showed a lower risk of cardiovascular events compared with those who took oral diabetes drugs, according to an analysis in the American Journal of Cardiology. The reduction in CV event risk may be due to DPP-IV inhibitors' ability to curb postprandial glucose levels and to increase the levels of angiogenesis-increasing HMGB1 protein, the study's authors said. Healio/Endocrine Today (9/28) LinkedInFacebookTwitterEmail this Story
 
  Hot Topics 

Top five news stories selected by AANP SmartBrief readers in the past week.

  • Results based on number of times each story was clicked by readers.
  Emerging Trends, Products and Technologies 
  • More U.S. children are hospitalized for serious abuse injuries
    U.S. researchers looked at records from surveys of 2,500 or more hospitals and found that cases of serious injuries from child abuse -- mostly fractures, open wounds and traumatic brain injuries -- slightly rose between 1997 and 2009. They also reported in the journal Pediatrics that babies younger than age 1 were more likely to be hospitalized than older children. Reuters (10/1) LinkedInFacebookTwitterEmail this Story
  Health Policy and Legislative News 
  • Analysis: Obama has shown he's open to Medicare change
    President Barack Obama has shown a willingness in the past to consider "hard decisions" on Medicare but continues to attack GOP presidential candidate Mitt Romney's plans, Jonathan Martin writes. The Democratic president has attacked what he calls plans to "voucherize" the program, but he's quietly made it clear he would accept large changes to Medicare if a deficit-reduction compromise can be reached. Politico (Washington, D.C.) (9/27) LinkedInFacebookTwitterEmail this Story
  AANP News 
  • Drug safety REMS
    The FDA has required a Risk Evaluation and Mitigation Strategy (REMS) for phentermine and topiramate extended release capsules (Qsymia) so that health care providers can be informed about the risk of teratogenicity associated with this therapy. Learn more about this REMS (PDF). LinkedInFacebookTwitterEmail this Story
  • Breast Cancer Awareness Month
    October is Breast Cancer Awareness Month. Presenting an opportunity to inform women about breast cancer screening for early detection, the CDC is providing updated promotional materials that anyone can use to raise awareness about this important issue. Download posters, flyers, advertisements, Web banners and buttons from the Right to Know page on CDC's website. LinkedInFacebookTwitterEmail this Story
Learn more about AANP ->Home Page | Join AANP | Legislation/Practice | CareerLink

  SmartQuote 
Inspiration exists, but it has to find us working."
--Pablo Picasso,
Spanish artist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AANP SmartBrief Issues:   Lead Editor:  Tom Parks
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information